DV
Dividend Vision

RDY — Dr. Reddy's Laboratories Limited

Dr. Reddy's Laboratories Limited (RDY)

RDY pays a 0.75% distribution rate, annual. Its Distribution Safety Score™ is 31 (Elevated risk), giving a Safety-Adjusted Yield of 0.23%. Total return is 1607.0% over the past 25.3 years, 659.4 points ahead of SPY at 947.6%. Its deepest 1-year drawdown was 25.8%.

Dr. Reddy's Laboratories Limited is an integrated pharmaceutical company headquartered in India that manufactures and markets generic and branded prescription drugs, over-the-counter medicines, biologics, and active pharmaceutical ingredients across North America, Europe, India, Russia, and other markets. The company operates a modest current distribution rate with annual distributions. The business appeals to income investors seeking pharmaceutical sector exposure with international diversification, though the modest yield may be of secondary importance to potential capital appreciation.

RDY key facts

Distribution Safety Score™
31 · Elevated risk
Safety-Adjusted Yield
0.23%
Asset type
Stock
Asset class
Equity
Inception date
04/11/2001
Distribution rate
0.75%
Distribution frequency
Annual
Trailing yield
1.05%
5-year average yield
0.72
Last close
$12.27
Market cap
$10,220,911,616
Average volume
2263200.0
Last dividend
$0.0643
Ex-dividend date
07/09/2026
Payment date
08/05/2026
Beta
0.242
Payout ratio
0.3517
P/E ratio
29.2143
Forward P/E
26.3852
EPS
$0.42